Clinical Trial

A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications

Study acronym: AF-BMC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 12, 2026 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
To assess the impact on body mass composition from anti-fibrotic medications used in fibrotic lung disease by using BIA and muscle ultrasound
Trial Details
NCT Number NCT07332117
Lead Sponsor Royal Brompton & Harefield NHS Foundation Trust
Conditions Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis
Enrollment 30 participants
Start Date 2025-09-09
Primary Completion 2026-04 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2026-01-12